Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
Viral Hepatitis
 Site Contents

 Hepatitis A

 Hepatitis B

 Hepatitis C
* Fact sheet
* FAQ
* Recommendations

 Hepatitis D

 Hepatitis E

 Resource Center

 Mission Statement


 On-line Training





     
Hepatitis Search:


Navigation Bar Hepatitis Home NCHSTP Home Contact Us

Fact Sheet

PDF Version pdf

SIGNS & SYMPTOMS 80% of persons have no signs or symptoms.
  • jaundice
  • fatigue
  • dark urine
  • abdominal pain 
  • loss of appetite
  • nausea
CAUSE
  • Hepatitis C virus (HCV)
LONG-TERM EFFECTS
  • Chronic infection: 75%-85% of infected persons
  • Cirrhosis: 20% of chronically infected persons
  • Deaths from chronic liver disease: 1%-5% of infected persons may die
  • Leading indication for liver transplant
TRANSMISSION

 

 

  • Occurs when blood from an infected person enters the body of a person who is not infected. 
  • HCV is spread through sharing needles or "works" when "shooting" drugs, through needlesticks or sharps exposures on the job, or from an infected mother to her baby during birth.
Recommendations for testing based on risk for HCV infection

Persons at risk for HCV infection might also be at risk for infection with hepatitis B virus (HBV) or HIV.

Recommendations for Testing Based on Risk for HCV Infection

PERSONS RISK OF INFECTION  TESTING RECOMMENDED?
Injecting drug users High Yes
Recipients of clotting factors made before 1987 High Yes
Hemodialysis patients Intermediate Yes
Recipients of blood and/or solid organs before 1992 Intermediate Yes
People with undiagnosed liver problems Intermediate Yes
Infants born to infected mothers Intermediate After age 12-18 mos.
Healthcare/public safety workers Low Only after known exposure
People having sex with multiple partners Low No*
People having sex with an infected steady partner Low No*

*Anyone who wants to get tested should ask their doctor.

PREVENTION
  • There is no vaccine to prevent hepatitis C.
  • Do not shoot drugs; if you shoot drugs, stop and get into a treatment program; if you can't stop, never share needles, syringes, water, or "works", and get vaccinated against hepatitis A & B.
  • Do not share personal care items that might have blood on them (razors, toothbrushes).
  • If you are a health care or public safety worker, always follow routine barrier precautions and safely handle needles and other sharps; get vaccinated against hepatitis B.
  • Consider the risks if you are thinking about getting a tattoo or body piercing. You might get infected if the tools have someone else's blood on them or if the artist or piercer does not follow good health practices.
  • HCV can be spread by sex, but this is rare. If you are having sex with more than one steady sex partner, use latex condoms* correctly and every time to prevent the spread of sexually transmitted diseases. You should also get vaccinated against hepatitis B.
  • If you are HCV positive, do not donate blood, organs, or tissue.
TREATMENT & MEDICAL MANAGEMENT

AASLD Practice Guideline: Diagnosis, Management, and Treatment of
Hepatitis C

 

  • HCV positive persons should be evaluated by their doctor for liver disease.
  • Interferon and ribavirin are two drugs licensed for the treatment of persons with chronic hepatitis C. 
  • Combination therapy, using pegylated interferon and ribavirin, is currently the treatment of choice.
  • Combination therapy can get rid of the virus in about 5 out of 10 persons for genotype 1 and in up to 8 out of 10 persons for genotype 2 and 3. 
  • Drinking alcohol can make your liver disease worse.
STATISTICS & TRENDS
  • Estimated number of new infections per year has declined from an average of 240,000 in the 1980s to about 19,000 in 2006.
  • Most infections are due to illegal injection drug use.
  • Transfusion-associated cases occurred prior to blood donor screening; now occur in less than one per 2 million transfused units of blood.
  • Estimated 4.1 million (1.6%) Americans have been infected with HCV, of whom 3.2 million are chronically infected.
  • The risk for perinatal HCV transmission is about 4%.
  • If coinfected with HIV, the risk for perinatal infection is about 19%.

* The efficacy of latex condoms in preventing infection with HCV is unknown, but their proper use may reduce transmission.
Top of page

Hepatitis Home | NCHHSTP Home | Contact Us
CDC Home | Search | Health Topics A-Z

This page last reviewed March 6, 2008

All information presented in these pages and all items available for download are for public use.

Division of Viral Hepatitis
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Department of Health and Human Services

US Department of Health and Human Services

Privacy Policy | Accessibility